Prolonged clotting time after CPB: heparin effect or factor deficiency?
After CPB, prolonged clotting time can reflect residual heparin, factor deficiency, dilution, hypothermia, sampling timing, or protamine effect. The key is not simply whether to give more protamine.
Clinical scenario
A 74-year-old woman undergoes mitral valve repair with CPB. After protamine, bleeding remains diffuse. ACT is only mildly prolonged compared with baseline. ROTEM shows prolonged clotting time in a heparin-sensitive channel, but the heparin-neutralized comparison is closer to normal. FIBTEM clot firmness is acceptable. Platelet count is 110,000/µL. Temperature is 35.8°C and pH is 7.31.
The team asks whether this is factor deficiency or residual heparin.
Reasoning goals
- Recognize that post-CPB prolonged clotting time is timing-dependent.
- Separate residual heparin effect from factor deficiency when heparin-sensitive and heparin-neutralized comparisons are available.
- Avoid treating clotting time prolongation as one diagnosis.
- Consider both protamine under-reversal and protamine excess.
- Correct physiology and reassess the bleeding.
- Keep surgical bleeding in the differential.
A. Why CPB timing matters
- CPB-in-progress, pre-protamine, post-protamine, and post-CPB bleeding are different clinical situations.
- Heparin exposure and reversal change how the VET pattern is interpreted.
B. What does the pattern suggest?
- Heparin-sensitive prolongation with improvement on the heparin-neutralized comparison suggests a residual heparin effect may be contributing.
- Acceptable fibrin-based clot firmness makes fibrinogen less likely as the dominant problem.
- Platelet contribution and the surgical field still matter.
C. What else can prolong clotting time?
- Factor deficiency or dilution
- Hypothermia
- Acidosis
- Sampling timing
- Protamine effect
- Ongoing bleeding
D. Protamine is not “more is always better”
- Under-reversal can leave a residual heparin effect.
- Excessive protamine can contribute to anticoagulant-like effects and platelet dysfunction.
- Additional protamine should be considered only when the pattern, ACT and heparin-sensitive data, timing, and institutional practice support it.
A prolonged clotting time is a pattern, not a diagnosis
Residual heparin and factor deficiency can produce a similar prolongation. The heparin-sensitive comparison, timing, and bleeding pattern are what separate them — the number alone does not.
E. Action frame
- Confirm the timing relative to CPB and protamine.
- Compare heparin-sensitive and heparin-neutralized channels.
- Review the ACT trend and the clinical bleeding.
- Inspect the surgical field.
- Correct temperature, pH, calcium, and dilution.
- Consider targeted protamine or factor replacement only if supported by the pattern.
- Reassess after intervention.
Take-home message
After CPB, prolonged clotting time is not automatically factor deficiency and not automatically residual heparin. It must be interpreted through timing, the heparin-sensitive comparison, physiology, and the bleeding pattern.
Clinical content by Kozo Watanabe, MD View profile →
Continue learning
Post-CPB diffuse bleeding: fibrinogen first or platelets first?
After CPB, diffuse bleeding with low fibrin-based clot firmness and reduced global clot strength can reflect fibrinogen deficit, platelet contribution, or both. The decision is pattern-based and must be reassessed.
Normalized ROTEM but bleeding persists: think surgical source
When viscoelastic results improve but bleeding continues, the next question is not always more product. Reassess the surgical field, source control, timing, and physiology.
Low MA / low clot stiffness after massive bleeding
After massive bleeding, low clot strength may reflect platelet contribution, fibrinogen contribution, dilution, physiology, or a mixed deficit. The key is to separate the components before choosing treatment.